SEC Form 4 · accession 0001179110-17-001924

MEDICINES CO /DE · MDCO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer

Period of report

Feb 3, 2017

Accepted (ET)

Feb 7, 2017 · 6:20 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001113481

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 3, 2017	M	10,833	$22.04	A	30,935	D
Common Stock^F1	Feb 3, 2017	S	10,833	$45.00	D	20,102	D
Common Stock	Feb 7, 2017	M	15,000	$28.60	A	35,102	D
Common Stock^F1,F2	Feb 7, 2017	S	12,100	$46.98	D	23,002	D
Common Stock^F1,F3	Feb 7, 2017	S	2,900	$47.45	D	20,102	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right-to-buy)^F6,F4	$22.04	Feb 3, 2017	M	10,833	D	—	Feb 24, 2022	Common Stock	10,833	0	D
Stock Option (right-to-buy)^F6,F5	$28.60	Feb 7, 2017	M	15,000	D	—	Feb 16, 2017	Common Stock	15,000	0	D

F1Sales were effected pursuant to a Rule 10b5-1 program adopted by the reporting person.
F2Represents the weighted average sales price of the shares sold ranging from a low of $46.35 to a high of $47.34 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3Represents the weighted average sales price of the shares sold ranging from a low of $47.35 to a high of $47.67 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4This option vested in forty-eight equal monthly installments beginning March 24, 2012.
F5This option vested in forty-eight equal monthly installments beginning March 16, 2007.
F6Not applicable.